Lung disease in cystic fibrosis (CF) starts early, with studies identifying abnormalities on chest computed tomography (CT) scan even in infancy. In this retrospective study, abnormal chest CT was the main outcome; body mass index (BMI) z score and forced expiratory volume percent predicted (FEV 1 %) predicted at age 6 to 7 years were secondary outcomes. Pseudomonas aeruginosa infection prior to 12 months of age was the main explanatory variable. There was no association between early P aeruginosa infection and abnormal CT after adjustment for CFTR (cystic fibrosis transmembrane conductance regulator) functional mutation class, gender, and other pathogens (odds ratio = 0.30; 95% confidence interval = 0.07-1.35; P = .11). No significant asso...
Rationale: Pseudomonas aeruginosa (Pa) is associated with poor pulmonary outcomes in cystic fibrosis...
Rationale: Recent data show that Aspergillus species are prevalent respiratory infections in childre...
Purpose of review Most treatment of newborn screening-diagnosed cystic fibrosis is not evidence-base...
AbstractBackgroundChildren with cystic fibrosis (CF) are often Pseudomonas aeruginosa (PsA) free and...
BACKGROUND: We previously reported relatively normal pulmonary function (2 years of age) and compute...
Background: Computed tomography (CT) is used to monitor progression of structural lung disease (SLD)...
Background: Infants with cystic fibrosis (CF) develop structural lung disease early in life, and vir...
Rationale: Pulmonary inflammation, infection, and structural lung disease occur early in life in chi...
Introduction: Pulmonary inflammation and infection are important clinical and prognostic markers of ...
The impact of on lung disease in young children with cystic fibrosis is uncertain.To determine if po...
The past decade has seen significant advances in understanding of the pathogenesis and progression o...
Little is known about early predictors of later cystic fibrosis (CF) structural lung disease. This s...
© Copyright 2017 by the American Thoracic Society. The past decade has seen significant advances in ...
To identify potential risk factors for lung disease progression in children with cystic fibrosis (CF...
In school-aged children with cystic fibrosis (CF) structural lung damage assessed using chest CT is ...
Rationale: Pseudomonas aeruginosa (Pa) is associated with poor pulmonary outcomes in cystic fibrosis...
Rationale: Recent data show that Aspergillus species are prevalent respiratory infections in childre...
Purpose of review Most treatment of newborn screening-diagnosed cystic fibrosis is not evidence-base...
AbstractBackgroundChildren with cystic fibrosis (CF) are often Pseudomonas aeruginosa (PsA) free and...
BACKGROUND: We previously reported relatively normal pulmonary function (2 years of age) and compute...
Background: Computed tomography (CT) is used to monitor progression of structural lung disease (SLD)...
Background: Infants with cystic fibrosis (CF) develop structural lung disease early in life, and vir...
Rationale: Pulmonary inflammation, infection, and structural lung disease occur early in life in chi...
Introduction: Pulmonary inflammation and infection are important clinical and prognostic markers of ...
The impact of on lung disease in young children with cystic fibrosis is uncertain.To determine if po...
The past decade has seen significant advances in understanding of the pathogenesis and progression o...
Little is known about early predictors of later cystic fibrosis (CF) structural lung disease. This s...
© Copyright 2017 by the American Thoracic Society. The past decade has seen significant advances in ...
To identify potential risk factors for lung disease progression in children with cystic fibrosis (CF...
In school-aged children with cystic fibrosis (CF) structural lung damage assessed using chest CT is ...
Rationale: Pseudomonas aeruginosa (Pa) is associated with poor pulmonary outcomes in cystic fibrosis...
Rationale: Recent data show that Aspergillus species are prevalent respiratory infections in childre...
Purpose of review Most treatment of newborn screening-diagnosed cystic fibrosis is not evidence-base...